The Perfect Stock: Eli Lilly & Co. (LLY)

     In 2015, Eli Lilly & Co. (LLY), the Indianapolis based, Big Pharma corporation, has gone up 22%.  As of one year ago, it has increased by 43%.  And, since I bought my stock in the company, less than two years ago, it has added 67% to its value.

The thesis of this blog is my belief that, at this time, Eli Lilly & Co. (LLY) is hosting a triangulation of upside factors that are feeding into a nexus of what I call: "The Perfect Stock".

First, the business is beginning to unveil eminent drugs that it may choose to put onto the market soon in the areas of: rheumatoid arthritis, Alzheimer's, and psoriasis.

Second, the products of hundreds of millions of dollars of research are going towards fueling the best minds with the private mandate to promote Eli Lilly (LLY), discover new science, and do further R&D.

Finally, there are able forces allied with the company that know that if the FDA misbehaves, it will have to be destroyed for a while.  This may not be a common, conventional, Wall Street factor.  But, it is not every company that has an Objectivist intellectual on its wing.

Paul Wharton
Special thanks to Eli Lilly & Co. (LLY)